ECIA
Encision Inc.0.1500
+0.0000+0%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
2.53MP/E (TTM)
-Basic EPS (TTM)
-0.03Dividend Yield
0%Recent Filings
8-K
10-Q
8-K
8-K
Encision secures $500K funding
Encision Inc. closed a $500,000 private placement on August 19, 2025, issuing 5 million common shares at $0.10 each to accredited investors, including directors, executives, and new shareholders. The funds will support ongoing operations and the early 2026 launch of a new ENT device. This bolsters liquidity while diluting existing shareholders. Yet risks like product acceptance loom large.
10-Q
Q1 FY2026 results
Encision's Q1 FY2026 revenue dipped 1.7% y/y to $1.6M, with product sales down 6% to $1.5M from fewer procedures, yet service revenue surged over 180% to $0.1M via a Vicarious Surgical deal. Gross profit fell 7% to $0.9M, trimming margins to 55% from 58%, while operating expenses eased 2% to $0.9M, yielding a slim operating loss of $20K versus $28K income last year. Net loss hit $41K, widened by $18K higher interest from debt, against prior profit; diluted EPS stayed flat at $(0.00) on 11.9M shares, with no dilution as options proved antidilutive. Cash drained to $48K after $116K operating outflow, but $1.2M working capital and $680K line availability buffer liquidity, alongside $320K line debt, $149K EIDL at 3.75%, and $60K equipment notes at 5-6%. FDA oversight on manufacturing looms as a key risk.
IPO
Website
Employees
Sector
Industry
AORT
Artivion, Inc.
45.91+0.54
ATRC
AtriCure, Inc.
41.08+0.04
CV
CapsoVision, Inc.
12.00-1.78
ENOV
Enovis Corporation
26.07-0.47
ISRG
Intuitive Surgical, Inc.
554.58-4.94
MMSI
Merit Medical Systems, Inc.
86.85+0.44
NOVT
Novanta Inc.
121.36+1.95
POCI
Precision Optics Corporation, I
4.20-0.07
UEEC
United Health Products, Inc.
0.06+0.00
VTAK
Catheter Precision, Inc.
2.19-0.04